openPR Logo
Press release

Analyzing the 2024 Drug Delivery Devices Market: Industry Trends, Growth Trajectories, and Forecasts Through 2033

04-16-2024 06:25 AM CET | Health & Medicine

Press release from: The Business research company

Drug Delivery Devices Market

Drug Delivery Devices Market

The drug delivery devices market size has grown strongly in recent years. It will grow from $87.65 billion in 2023 to $94.7 billion in 2024 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to rapid growth in elderly population, growth in the number of healthcare facilities, economic growth in the emerging markets and increased healthcarew expenditure.

The drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $122.07 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increase in prevalence of chronic diseases, increasing demand from injectables, increasing demand for drug delivery devices and sudden emergence of severe infectipns . Major trends in the forecast period include investing in microneedle drug technology for drug delivery, research and development ofself-injectable drug delivery devices, focusing on mergers and acquisitions and investing in wearable drug delivery devices.

Market Overview -
Drug delivery devices are used to deliver specific drugs to a specific part of the body to cure diseases. Drug delivery devices used in various patient care settings, such as hospitals, diagnostic centers, clinics, and home care settings, are included in this market.

Download Free Sample of Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=2833&type=smp

Chronic Diseases Fueling Growth In Drug Delivery Devices Market
The rising prevalence of chronic diseases such as cardiovascular diseases, diabetes, cancer and other diseases is expected to drive the drug delivery devices market. For instance, in January 2023, according to the National Library of Medicine, a US-based medical library operated by the federal government, the number of individuals in the United States aged 50 and older who have at least one chronic condition is projected to increase by 99.5%. This increase would see the number rise from 71.522 million in 2020 to 142.66 million by 2050. There are various routes of drug administration for medical drugs. The selection of the route depends on three factors - the effect desired; the type of the disease and the type of the product. Currently, the development of new drug delivery systems plays a major role in the pharmaceutical industry. Research and development (R&D) in drug delivery is increasing throughout the world due to the increasing prevalence of these diseases. Most pharmaceutical companies are focusing on multiple drug delivery technologies to create excellent advantages and better outcomes for their marketed products. Hence, the increasing prevalence of chronic diseases is resulting in increased consumption of therapeutic drugs and therapies, and this factor is expected to act as a driver for the growth of the drug delivery devices market.

Competitive Landscape -
Major companies operating in the drug delivery devices market report are Becton, Dickinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, 3M Company, West Pharmaceutical Services, Inc., Gerresheimer AG, Smiths Medical, Boehringer Ingelheim, SMC Ltd., Elcam Medical, Eli Lilly and Company, Gerresheimer, Injex, Novartis AG, Novo Nordisk A/S, Pfizer Inc, Sanofi Sa, Schott AG, Terumo Corporation, Teva Pharmaceuticals, West Pharmaceuticals, Ypsomed Holding AG, F. Hoffmann-La Roche AG, GlaxoSmithKline, AstraZeneca, Congenica Ltd., UCB, Alkermes, Aptalis Pharma, Inc., Johnson & Johnson, Nektar Therapeutics, SkyePharma PLC, Pharmasyntez, NEARMEDIC PLUS LLC, Copernicus, Medtronic, Philips, Siemens, Stryker, GE Healthcare, Teleflex Medical, Gilero, Kedalion Therapeutics, MediPrint Ophthalmics, Nemera, Pendant Biosciences, Battelle Medical Devices, Merck & Co. Inc., Antares Pharma, Abbot, Allergan, Bilim Pharmaceuticals, H&T Presspart, Hovione Technology, Sorrel Medical, Syqe Medical, Julphar, ResMed Inc, Covidien plc

Connectivity In Drug Delivery Devices That Is Innovative Focusing On Autoinjectors To Improve The Patient Experience
Major companies operating in the drug delivery device market are focusing on developing innovative devices such as autoinjectors with completely built-in connectivity to gain a competitive edge in the market. Autoinjectors are medical devices designed for the self-administration of a pre-measured dose of medication. For instance, in December 2021, Ypsomed AG, a Switzerland-based manufacturer of injection and infusion equipment, launched YpsoMate, an autoinjector with fully integrated connectivity. The device has built-in Bluetooth communication as standard, which can connect to mobile phones and tablets to transfer injection and device data. The autoinjector offers digital therapy support through integrated connectivity, automatically recording the administration of medication and providing data to healthcare providers.

Browse Full Report @
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Key Segments -
The drug delivery devices market covered in this report is segmented -
1) By Route Of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery
2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings
3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Analyzing the 2024 Drug Delivery Devices Market: Industry Trends, Growth Trajectories, and Forecasts Through 2033 here

News-ID: 3464986 • Views:

More Releases from The Business research company

Leading Companies Fueling Innovation and Growth in the Partyline Intercom Systems Market
Leading Companies Fueling Innovation and Growth in the Partyline Intercom System …
The partyline intercom systems market is gearing up for significant expansion as communication needs evolve across various industries. With increasing demand for more versatile and efficient communication tools, this sector is set to witness rapid advancements and growing adoption over the coming years. Let's explore the market size projections, key drivers, major players, emerging trends, and important segments shaping this dynamic industry. Projected Market Size and Growth Trajectory of the Partyline
Open Source Vulnerability Scanner Market Analysis: Major Segments, Strategic Developments, and Leading Companies
Open Source Vulnerability Scanner Market Analysis: Major Segments, Strategic Dev …
The open source vulnerability scanner market is positioned for significant growth as cybersecurity concerns intensify across industries. With the increasing complexity of IT environments and the widespread adoption of cloud-native technologies, demand for effective and automated vulnerability management tools is surging. This overview explores the predicted market expansion, key industry players, emerging trends, and segmentation that define this evolving landscape. Open Source Vulnerability Scanner Market Size and Projected Growth Through 2030
Segment Breakdown and Major Growth Areas in the Off Highway Vehicle Lighting Market
Segment Breakdown and Major Growth Areas in the Off Highway Vehicle Lighting Mar …
The off highway vehicle lighting market is poised for significant expansion in the coming years, driven by technological advancements and evolving industry demands. This sector is witnessing a surge in innovation and adoption, which is expected to shape its trajectory through 2030. Let's explore the market size, key players, emerging trends, and detailed segmentation to better understand this growing industry. Off Highway Vehicle Lighting Market Size Forecast and Growth Drivers
Key Strategic Developments and Emerging Changes Shaping the Network Slicing Analytics Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Network Slicing Anal …
The network slicing analytics market is on the verge of remarkable expansion as industries increasingly rely on advanced network technologies. With the rapid evolution of 5G and edge computing, there is a growing need for sophisticated analytics to manage complex network slices efficiently. This overview will explore the market's projected growth, key players, emerging trends, and segment breakdowns shaping the future of network slicing analytics. Projected Growth and Market Size of

All 5 Releases


More Releases for Drug

Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights: * Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029 * Global and Regional Antibody Drug Conjugate Market Insight * Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023 * Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight * Insight On Antibody Drug Conjugates In Clinical Trials: > 550
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase